| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5537332 | Vaccine | 2016 | 7 Pages |
Abstract
The Chinese government should take steps to reduce the burden of pneumococcal diseases among young children through the inclusion of a pneumococcal conjugate vaccine in its EPI. Although all vaccinations would be cost-effective, PCV-13 would save more costs to the healthcare system and would be the preferred strategy.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Kristin A. Maurer, Huey-Fen Chen, Abram L. Wagner, Sonia T. Hegde, Tejasi Patel, Matthew L. Boulton, David W. Hutton,